Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of VRK1 protein | affects expression | 20106945
|
C015001 |
arsenite |
arsenite results in decreased expression of VRK1 mRNA | decreases expression | 18929588
|
D001205 |
Ascorbic Acid |
[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of VRK1 mRNA | affects cotreatment|decreases expression | 16443354
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of VRK1 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VRK1 mRNA | decreases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of VRK1 mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of VRK1 mRNA | affects cotreatment|decreases expression | 16443354
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.80 | 6695378 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.84 | 15955085 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.43 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.23 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.41 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.73 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.89 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
2.00 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.00 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.99 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.60 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.18 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.18 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.79 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.79 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.24 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.17 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.17 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.99 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.12 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.60 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.76 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.06 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.62 | 15037631 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.92 | 17323712 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9211117 9125849 9224671 8800419 16925845 14991402 10589399 9142499 9664655 17551590 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
3.15 | 16506275 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.92 | 9068938 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.91 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.28 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.54 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.54 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.78 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
8.89 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.89 | 19224547 |
MESH:D005355 |
Fibrosis |
|
arsenite |
17.07 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
17.07 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
17.07 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.17 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.36 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.60 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
12.04 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
12.04 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
12.04 | 14991402 9664655 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.55 | 16863852 16490937 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.43 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.93 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.18 | 10903974 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.12 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.18 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.48 | 18776723 8314463 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.97 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.89 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.98 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.32 | 19642359 16823087 17339181 19029980 17712046 17361223 17368321 17301526 17107899 19035177 16331271 17506722 15748426 9834237 16140955 17649720 16766008 17294898 17217047 19225113 12679006 16935935 16788101 19075265 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.50 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.55 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.86 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.86 | 21137059 20195826 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.87 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
6.87 | 18544905 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
4.12 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
5.14 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
5.14 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
5.14 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.14 | 17053015 20064080 20135361 20464547 18520028 18816296 6695378 18569708 20869020 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.87 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.78 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.40 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.22 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.39 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.39 | 16594593 16946489 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.81 | 15738583 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.11 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.22 | 9142499 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
3.19 | 17217161 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.41 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.54 | 15976015 |
MESH:C548069 |
Pontocerebellar Hypoplasia Type 1 |
marker/mechanism |
|
| |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.47 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.93 | 17292933 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.91 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.19 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.78 | 14606601 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.37 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.40 | 16116481 16283617 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.27 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.06 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.06 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.40 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
4.17 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
4.51 | 16517955 16403987 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.23 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.05 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.38 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.26 | 17053015 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.94 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.05 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.39 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.22 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |